Holen Sie sich die Stockscreener-App
7.79
1.30%
0.10
Schlusskurs vom Vortag:
$7.69
Offen:
$7.88
24-Stunden-Volumen:
1.10M
Relative Volume:
0.94
Marktkapitalisierung:
$548.52M
Einnahmen:
$11.40B
Nettoeinkommen (Verlust:
$-95.73M
KGV:
-3.1796
EPS:
-2.45
Netto-Cashflow:
$-64.37M
1W Leistung:
+7.30%
1M Leistung:
+23.45%
6M Leistung:
+4.70%
1J Leistung:
+7.97%
1-Tages-Spanne:
$7.72
$8.005
1-Wochen-Bereich:
$7.23
$8.005
52-Wochen-Spanne:
$4.70
$10.44
Mind Medicine Inc Stock (MNMD) Company Profile
Firmenname
Mind Medicine Inc
Sektor
Branche
Telefon
212-220-6633
Adresse
ONE WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
7.79 | 548.52M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-10-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-07-24 | Eingeleitet | ROTH MKM | Buy |
| 2024-05-29 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-12-09 | Fortgesetzt | ROTH Capital | Buy |
| 2022-11-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-26 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Eingeleitet | ROTH Capital | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
(MNMD) Investment Report - news.stocktradersdaily.com
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances - Investing.com Australia
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances By Investing.com - Investing.com UK
Why Mind Medicine Gave Investors a Powerful Buzz in May - AOL.com
Why is Mind Medicine (MNMD) Stock Moving Today? - GuruFocus
Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade - MSN
MindMed Issues Inducement Grants to New Employees - TipRanks
MindMed Appoints Brandi Roberts as CFO to Drive Growth and Commercialization - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treat - GuruFocus
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treatment | MNMD Stock News - GuruFocus
Cantor Fitzgerald maintains Overweight rating on MindMed stock By Investing.com - Investing.com India
MindMed to Participate in June Investor Conferences | MNMD Stock News - GuruFocus
MindMed to Participate in June Investor Conferences - The Globe and Mail
MindMed's Brain Health Breakthroughs Take Center Stage at Jefferies and H.C. Wainwright Conferences - Stock Titan
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - StreetInsider
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD S - GuruFocus
MindMed Strengthens Executive Team with Appointment of Brandi Ro - GuruFocus
Mind Medicine Names Brandi Roberts CFO - marketscreener.com
Mindmed Strengthens Executive Team With Appointment Of Brandi Roberts As Chief Financial Officer - marketscreener.com
Mind Medicine Appoints New Chief Financial Officer - TipRanks
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD Stock News - GuruFocus
MindMed appoints Brandi L. Roberts as CFO By Investing.com - Investing.com India
MindMed appoints Brandi L. Roberts as CFO - Investing.com Australia
2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com
MindMed Appoints Brandi Roberts, CPA, as Chief Financial Officer - citybiz
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer | MNMD Stock News - GuruFocus
(MNMD) Trading Signals - news.stocktradersdaily.com
Analysts Set Expectations for MNMD Q1 Earnings - Defense World
FY2025 EPS Estimates for MNMD Cut by Cantor Fitzgerald - Defense World
Northern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed at RBC Conference: Progress in Psychedelic Therapies By Investing.com - Investing.com India
MindMed at RBC Conference: Progress in Psychedelic Therapies - Investing.com
Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential - Insider Monkey
MNMD Stock Rises Amid Connecticut's Psilocybin Decriminalization Bill - GuruFocus
Why Mind Medicine Stock Vaulted More Than 8% Higher Today - Yahoo
Mind Medicine (MNMD) Stocks Climb Amid FDA Focus on Psychedelics - GuruFocus
Psychedelic stocks up after FDA chief’s comments (ATAI:NASDAQ) - Seeking Alpha
MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus
MindMed Announces New Employee Inducement Grants - Business Wire
Price T Rowe Associates Inc. MD Acquires 8,361 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Insider Monkey
(MNMD) Technical Data - news.stocktradersdaily.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Upgraded at Cantor Fitzgerald - Defense World
Analysts Offer Predictions for MNMD FY2025 Earnings - Defense World
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of “Buy” by Analysts - Defense World
Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - MSN
Raymond James Financial Inc. Makes New $111,000 Investment in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed projects 2026 trial readouts for pivotal MM120 studies in GAD and MDD - MSN
Finanzdaten der Mind Medicine Inc-Aktie (MNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):